Skip to main content
. 2022 Jun 23;13:848456. doi: 10.3389/fgene.2022.848456

FIGURE 1.

FIGURE 1

Expression level of P4HA1 in distinct cancers and pathological stages. (A) Expression level of the P4HA1 in distinct tumors or specific tumor subtypes was analyzed by TIMER2.0 (http://timer.cistrome.org/). (B) We analyzed the expression level of P4HA1 in DLBC, LGG UCS, and LAML in the TCGA project and GTEx database. (C) Total protein expression level of P4HA1 in BRCA, OV, colon cancer, ccRCC, UCEC, and LUAD was analyzed according to the CPTAC dataset (http://ualcan.path.uab.edu/). (D) On the basis of the TCGA dataset, the expression level of P4HA1 was analyzed by the main pathological stages (stage I, stage II, stage III, and stage IV) of ACC, CESC, HNSC, KICH, KIRP, LUAD, and TGCT. *p < 0.05, **p < 0.01, and ***p < 0.001; log2 (TPM + 1) was applied for log-scale.